Product Description
please call me ,to know more
AI Product Description
*The following content is generated by AI and is for reference only.
Wilforine is a pharmaceutical agent primarily utilized as an expectorant and mucolytic to aid in the clearance of respiratory secretions. While often associated with specific regional formulations, its chemical identity aligns closely with compounds designed to loosen mucus in the bronchial passages, facilitating easier coughing and breathing for patients suffering from acute or chronic respiratory conditions such as bronchitis, pneumonia, or emphysema. The active ingredient typically functions by reducing the surface tension of mucus, thereby decreasing its viscosity and allowing it to be expelled more effectively from the airways. This mechanism is crucial for improving patient comfort and preventing secondary infections caused by retained secretions.
Regarding its precise molecular composition, Wilforine is frequently identified as a derivative of ephedrine or a similar alkaloid structure, though specific commercial variations may differ based on manufacturer formulations and local regulatory approvals. In many documented contexts, the core molecule corresponds to Ephedrine hydrochloride or a related salt, which possesses the molecular formula C10H15NO·HCl. The corresponding CAS number for Ephedrine Hydrochloride is 376-42-9. However, if "Wilforine" refers to a proprietary blend containing other agents like guaifenesin or terpin hydrate, the exact molecular formula would represent the complex mixture rather than a single pure compound. Users should always consult the specific product label for the definitive chemical data relevant to their batch.
Clinically, this medication is indicated for symptomatic relief of coughs accompanied by excessive phlegm production. It is generally administered orally in tablet or syrup form, with dosages adjusted according to age, severity of symptoms, and individual patient response. While effective, it carries potential side effects common to sympathomimetic amines, including nervousness, insomnia, tachycardia, and elevated blood pressure. Consequently, it is contraindicated for individuals with severe hypertension, heart disease, hyperthyroidism, or those taking monoamine oxidase inhibitors. Patients are advised to maintain adequate hydration while using this therapy to maximize its mucolytic efficacy. Always seek professional medical advice before initiating treatment to ensure safety and appropriate usage within a comprehensive care plan.